Papers: 10.1186/s13058-021-01408-9

https://doi.org/10.1186/s13058-021-01408-9

An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer

Cited by: 17
Author(s): Erica Stringer-Reasor, Jori E. May, Eva Olariu, Valerie Caterinicchia, Yufeng Li, Dongquan Chen, Deborah L. Della Manna, Maria Pisu, Christos Vaklavas, Carla I. Falkson, Lisle Nabell, Edward P. Acosta, Andres Forero‐Torres, Eddy S. Yang
Published: over 5 years ago

Software Mentions 2